Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VVUS: VIVUS INC. (NASDAQ) -- Ignore unavailable to you. Want to Upgrade?

To: Tim Gardner who wrote (9014)	6/3/1998 1:33:00 PM
From: g.w. barnard	Respond to of 23519

tim, he is just following the lead from cnbc today. geez did they put a negitive spin or what? joe mentioned ineffectiveness of product and some earnings revised downward to loss of 45cents also the new scrits down over 70%. no mention of the positive side of the equation, the european study for efficacy, the pill format, safety feature. guess i am a little testy today. gw

To: Tim Gardner who wrote (9014)	6/3/1998 1:50:00 PM
From: RT	Read Replies (2) \| Respond to of 23519

Jim, I commend you on your ability to withstand the agony that this company has bestowed on us. Hell on earth is owning Vivus. Perhaps these studies were flawed, but if they were, why haven't those inept bastards responded. Leland should have had investigators research these reports and responded aggressively. No comment, leads one to believe that the studies are valid. This limp dick management couldn't manage a lemonade stand. Oust the as*holes, Nina included. RT